Forbes Medi-Tech




Previous All pages Next 1 2 3 4 5 6 7 Page 8 9
August 19, 2003  Forbes Medi-Tech announces Financial Results for the Second Quarter ended June 30, 2003 - Second Quarter Revenues up 30%, Company Improves Operating Results
August 13, 2003  Forbes Medi-Tech Announces Closing of Phyto-Source Financing
August 12, 2003  Forbes Medi-Tech Announces Timing of Second Quarter Financial Results
July 18, 2003  Forbes Medi-Tech Signs International Reducol (tm) Sales and Licensing Agreement
July 15, 2003  Forbes Medi-Tech Maintains Nasdaq SmallCap Listing
July 02, 2003  Forbes Medi-Tech To Receive US$3 Million Partial Loan Repayment From Phyto-Source Manufacturing Joint Venture
June 27, 2003  Forbes Medi-Tech Announces US$2 Million Increase in Revenue Guidance Based on Growth in Sterol Sales
May 30, 2003  Forbes Medi-Tech AGM Update
May 05, 2003  Forbes Medi-Tech announces Financial Results for the Year ended December 31, 2002 and First Quarter ended March 31, 2003
May 01, 2003  Forbes Medi-Tech Announces Timing of Year End, First Quarter Financial Results and AGM
April 29, 2003  Forbes Medi-Tech Responds to Pan Pharmaceutical News
April 29, 2003  Forbes Medi-Tech Sells AD & ADD Technology for US$1.9 Million
April 16, 2003  Forbes Medi-Tech Announces NASDAQ Extension and Advisory Board Restructuring
March 04, 2003  Forbes Medi-Tech Announces Pharmavite Contract Extension
February 27, 2003  US FDA Issues Health Claim Letter to Forbes
January 27, 2003  Forbes Medi-Tech Completes Phase I Safety Study on FM-VP4
January 20, 2003  Forbes Medi-Tech Initiates Dosing for Phase II clinical trials on FM-VP4
January 15, 2003  Forbes Medi-Tech Begins Sterol Shipments Under Major Supply Agreement
December 20, 2002  Forbes Medi-Tech Announces Management Changes
December 11, 2002  Forbes Medi-Tech Fights Cholesterol with Chocolate
December 09, 2002  Special Warrant Investors Waive Requirement for Prospectus
December 04, 2002  Forbes Medi-Tech Provides Status of Pharmaceutical Development and Health Claim Status for Phytosterols
November 26, 2002  Forbes Medi-Tech Announces Third Quarter Results, Improves Financial Position and Outlook
November 20, 2002  Forbes Medi-Tech Announces Timing of Third Quarter Financial Results
November 14, 2002  Forbes Medi-Tech's Cholesterol-Lowering Oil Featured in Presentation at American Heart Association Conference
Previous All pages Next 1 2 3 4 5 6 7 Page 8 9